Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?4.65

?4.65

 
WKN: 564868 / Symbol: DRRX / Name: DURECT / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€4.65
01.04.24
-
buy
03.03.24
-
17.02.24
-
16.09.23
-
14.09.23
-
buy
26.08.23
-
Your prediction

Durect Corp. Stock

Our community is currently low on Durect Corp. with 2 Buy predictions and 4 Sell predictions.
However, we have a potential of 969.52% for Durect Corp. as the target price of 4 € is above the current price of 0.37 €.
For the coming years our community has positive and negative things to say abot the Durect Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Durect Corp. in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Durect Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Durect Corp. - - - - - - -
Ardelyx Inc. -0.970% -1.275% -10.651% 49.136% 4.498% -13.094% -
Salarius Pharmaceuticals Inc. -1.840% 0.472% 0.472% -70.417% -23.243% -98.362% -99.993%
Brainstorm Cell -5.760% -2.456% -5.429% -82.011% 114.009% -82.879% -

Comments

Prediction Buy
Perf. (%) -
Target price 4.653
Change
Ends at 01.04.25

DURECT Co. (NASDAQ: DRRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $5.00 price target on the stock.
Ratings data for DRRX provided by MarketBeat
Show more

DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for DRRX provided by MarketBeat
Show more

DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for DRRX provided by MarketBeat
Show more